ArticleJournal of critical care2022

MR-proADM has a good ability to predict 28-day mortality in critically ill patients with SARS-CoV-2 pneumonia: Beware of some potential confounders!

Patrick M Honore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.